- Home
- CRBP vs CHMG Comparison
CRBP vs CHMG Comparison
Compare CRBP & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- CHMG
- Stock Information
- Founded
- CRBP 2009
- CHMG 1833
- Country
- CRBP United States
- CHMG United States
- Employees
- CRBP N/A
- CHMG N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- CHMG Major Banks
- Sector
- CRBP Health Care
- CHMG Finance
- Exchange
- CRBP Nasdaq
- CHMG Nasdaq
- Market Cap
- CRBP 227.3M
- CHMG 222.5M
- IPO Year
- CRBP N/A
- CHMG N/A
- Fundamental
- Price
- CRBP $16.73
- CHMG $50.64
- Analyst Decision
- CRBP Strong Buy
- CHMG Hold
- Analyst Count
- CRBP 7
- CHMG 1
- Target Price
- CRBP $65.86
- CHMG $49.00
- AVG Volume (30 Days)
- CRBP 346.4K
- CHMG 14.3K
- Earning Date
- CRBP 11-07-2024
- CHMG 10-22-2024
- Dividend Yield
- CRBP N/A
- CHMG 2.48%
- EPS Growth
- CRBP N/A
- CHMG N/A
- EPS
- CRBP N/A
- CHMG 4.53
- Revenue
- CRBP N/A
- CHMG $93,478,000.00
- Revenue This Year
- CRBP N/A
- CHMG N/A
- Revenue Next Year
- CRBP N/A
- CHMG $9.64
- P/E Ratio
- CRBP N/A
- CHMG $11.07
- Revenue Growth
- CRBP N/A
- CHMG N/A
- 52 Week Low
- CRBP $4.00
- CHMG $39.00
- 52 Week High
- CRBP $61.90
- CHMG $52.59
- Technical
- Relative Strength Index (RSI)
- CRBP 37.25
- CHMG 58.48
- Support Level
- CRBP $15.65
- CHMG $50.10
- Resistance Level
- CRBP $17.18
- CHMG $52.10
- Average True Range (ATR)
- CRBP 1.26
- CHMG 0.88
- MACD
- CRBP 0.35
- CHMG -0.02
- Stochastic Oscillator
- CRBP 21.09
- CHMG 65.34
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. It provides financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, securities, and insurance brokerage services. Its business operations are organized into two lines of business: Banking, and Wealth Management services. It derives its revenues from the core banking business.